Switzerland Investment Grade Healthcare & Pharmaceuticals Corporate Bond Yields (CHF)
Fitted spot curve as of 2026-10-26
https://bondscovery.com/yield-curve/chf-corporate-healthcare-pharmaceuticals-switzerland
Switzerland Investment Grade Healthcare & Pharmaceuticals Corporate Bond Yields (CHF) as of 2026-10-26: 10Y at 1.23%, fitted curve 3M–25Y (0.10%–1.40%), 34 bonds. Live chart, constituents and forward rates on bondScovery.
| Maturity | Fitted yield | Forward rate |
|---|---|---|
| 3M | 0.10% | — |
| 9M | 0.32% | 0.43% |
| 18M | 0.55% | 0.83% |
| 2Y | 0.65% | 0.90% |
| 3Y | 0.82% | 1.15% |
| 4Y | 0.94% | 1.33% |
| 5Y | 1.04% | 1.43% |
| 6Y | 1.11% | 1.47% |
| 7Y | 1.16% | 1.47% |
| 8Y | 1.19% | 1.44% |
| 9Y | 1.22% | 1.42% |
| 10Y | 1.23% | 1.40% |
| 15Y | 1.36% | 1.65% |
| 25Y | 1.40% | 1.47% |
2Y, 10Y and the 10Y−2Y spread over time
The 2-year yield is 0.65% and the 10-year 1.23%, a 10Y−2Y spread of +58 bp — positively sloped — as of 2026-10-26. The chart and table below track how they have moved.
Fitted 2Y and 10Y yields and their spread, sampled one build date per month. See all inverted curves today →
| Tenor | Latest2026-10-26 | 1m ago2026-09-25 | 2m ago2026-08-27 | 3m ago2026-07-28 | 4m ago2026-06-29 | 5m ago2026-05-29 | 6m ago2026-04-29 |
|---|---|---|---|---|---|---|---|
| 2Y | 0.65% | 0.94% | 0.73% | 0.82% | 0.71% | 0.75% | 0.80% |
| 10Y | 1.23% | 1.40% | 1.26% | 1.27% | 1.13% | 1.27% | 1.22% |
| 10Y − 2Y | +58 bp | +46 bp | +53 bp | +46 bp | +42 bp | +52 bp | +42 bp |
Yields by rating group
The same curve split by credit quality: 34 rated bonds across 2 rating bands, all maturities pooled. Median yield by band: AAA to AA- 1.08%, A+ to BBB- 1.25%.
Bonds in this curve
A selection of 30 of the 34 bonds behind this curve, spread across maturities.
| Issuer | Yield | Maturity | Coupon | ISIN |
|---|---|---|---|---|
| Roche | 0.26% | 2027-02-25 | 0.50% | CH1166151899 |
| Novartis | 0.10% | 2027-06-18 | 1.60% | CH1353257806 |
| Sandoz Group | 0.76% | 2028-03-31 | 1.25% | CH1428867027 |
| Roche | 0.56% | 2028-09-15 | 1.60% | CH1305916764 |
| Galderma | 1.02% | 2028-09-27 | 1.60% | CH1373904403 |
| Galderma | 1.02% | 2029-03-20 | 1.40% | CH1399999973 |
| Roche | 0.73% | 2029-09-06 | 0.98% | CH1371736807 |
| Novartis | 0.71% | 2029-11-13 | 0.62% | CH0270190991 |
| Roche | 0.75% | 2030-05-27 | 0.46% | CH1474857013 |
| Roche | 0.91% | 2030-09-24 | 0.75% | CH0433761316 |
| Roche | 0.93% | 2031-02-25 | 0.75% | CH1166151907 |
| Novartis | 0.92% | 2031-06-18 | 1.65% | CH1353257814 |
| Roche | 0.97% | 2031-11-26 | 0.78% | CH1593191021 |
| Sandoz Group | 1.25% | 2032-04-15 | 1.19% | CH1543592732 |
| Roche | 0.99% | 2032-09-23 | 2.00% | CH1211713230 |
| Galderma | 1.38% | 2033-03-18 | 1.81% | CH1399999981 |
| Sandoz Group | 1.45% | 2033-03-31 | 1.75% | CH1428867035 |
| Roche | 1.08% | 2033-09-15 | 1.75% | CH1305916772 |
| Novartis | 1.10% | 2034-06-16 | 1.75% | CH1353257822 |
| Roche | 1.09% | 2034-09-06 | 1.10% | CH1371736815 |
| Novartis | 1.11% | 2035-05-11 | 1.05% | CH0270191007 |
| Roche | 1.10% | 2035-08-27 | 0.88% | CH1474857021 |
| Sandoz Group | 1.55% | 2036-04-15 | 1.55% | CH1543592740 |
| Roche | 1.13% | 2036-08-26 | 1.09% | CH1593191039 |
| Roche | 1.20% | 2037-02-25 | 1.00% | CH1166151915 |
| Roche | 1.28% | 2038-09-15 | 1.95% | CH1305916780 |
| Roche | 1.22% | 2039-09-06 | 1.17% | CH1371736823 |
| Novartis | 1.35% | 2040-06-18 | 1.85% | CH1353257830 |
| Roche | 1.32% | 2040-08-27 | 1.13% | CH1474857039 |
| Novartis | 1.38% | 2049-06-18 | 1.85% | CH1353257848 |